支气管扩张症:新疗法与新视角
本文系统综述了成人支气管扩张症处于临床开发阶段的候选药物,涵盖靶向气道及全身炎症、黏液纤毛清除及上皮功能障碍的疗法。作者提出应重新评估当前治疗策略,鉴于支气管扩张症为异质性疾
要点
- 目前全球尚无获批的支气管扩张症治疗药物,临床疗法多缺乏证据。
- 新药研发聚焦气道及全身炎症、黏液纤毛清除和上皮功能障碍。
- 建议采用可治疗特征策略,未来试验应靶向最可能获益的特定亚组。
核心结论
- 支气管扩张症治疗选择匮乏,亟需开发新疗法。
- 支气管扩张症是异质性疾病,由多种生物机制驱动疾病进展。
- 可借鉴哮喘和慢阻肺的可治疗特征策略,未来试验应针对特定亚组。
研究设计与样本
- 系统综述科学文献和临床试验注册库,识别成人支气管扩张症早期至晚期临床开发阶段的药物。
主要发现
- 讨论了靶向气道及全身炎症、黏液纤毛清除和上皮功能障碍的新兴疗法的机制和潜在作用。
- 对支气管扩张症病理生理学的理解尚处于早期阶段。
临床怎么用
- 临床实践中多数疗法基于极少证据,全球尚无获批药物。
- 未来试验应针对最可能获益的特定疾病亚组,采用可治疗特征策略。
局限性
- 对支气管扩张症病理生理学的理解尚处于早期阶段。
- 临床实践中使用的多数疗法基于极少证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
European Respiratory Society guidelines for the management of adult bronchiectasis highlight the paucity of treatment options available for patients with this disorder. No treatments have been licensed by regulatory agencies worldwide, and most therapies used in clinical practice are based on very little evidence. Development of new treatments is needed urgently. We did a systematic review of scientific literature and clinical trial registries to identify agents in early-to-late clinical development for bronchiectasis in adults. In this Review, we discuss the mechanisms and potential roles of emerging therapies, including drugs that target airway and systemic inflammation, mucociliary clearance, and epithelial dysfunction. To ensure these treatments achieve success in randomised clinical trials-and therefore reach patients-we propose a reassessment of the current approach to bronchiectasis. Although understanding of the pathophysiology of bronchiectasis is at an early stage, we argue that bronchiectasis is a heterogeneous disease with many different biological mechanisms that drive disease progression (endotypes), and therefore the so-called treatable traits approach used in asthma and chronic obstructive pulmonary disease could be applied to bronchiectasis, with future trials targeted at the specific disease subgroups most likely to benefit.
引用
- Chalmers JD, Chotirmall SH. Bronchiectasis: new therapies and new perspectives. Lancet Respir Med. 2018. PMID: 29478908. doi:10.1016/S2213-2600(18)30053-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。